375 related articles for article (PubMed ID: 15217933)
61. Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in min mice.
Møllersen L; Paulsen JE; Alexander J
Anticancer Res; 2004; 24(5A):2595-9. PubMed ID: 15517863
[TBL] [Abstract][Full Text] [Related]
62. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
63. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
64. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
65. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
66. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
67. Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer.
Bougatef K; Ouerhani S; Moussa A; Kourda N; Coulet F; Colas C; Lahely YB; Najjar T; Ben Jilani S; Benammar-Elgaaied A; Soubrier F; Marrakchi R
Cancer Genet Cytogenet; 2008 Nov; 187(1):12-8. PubMed ID: 18992635
[TBL] [Abstract][Full Text] [Related]
68. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.
Jass JR; Biden KG; Cummings MC; Simms LA; Walsh M; Schoch E; Meltzer SJ; Wright C; Searle J; Young J; Leggett BA
J Clin Pathol; 1999 Jun; 52(6):455-60. PubMed ID: 10562815
[TBL] [Abstract][Full Text] [Related]
69. [APC mutation analysis in sporadic colorectal cancer].
Huang J; Zheng S; Jin S
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):415-8. PubMed ID: 9387290
[TBL] [Abstract][Full Text] [Related]
70. Combined analysis of microsatellite instability and K-ras mutation increases detection incidence of normal samples from colorectal cancer patients.
Minamoto T; Esumi H; Ochiai A; Belitsky G; Mai M; Sugimura T; Ronai Z
Clin Cancer Res; 1997 Aug; 3(8):1413-7. PubMed ID: 9815826
[TBL] [Abstract][Full Text] [Related]
71. A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instability.
Westra JL; Boven LG; van der Vlies P; Faber H; Sikkema B; Schaapveld M; Dijkhuizen T; Hollema H; Buys CH; Plukker JT; Kok K; Hofstra RM
Genes Chromosomes Cancer; 2005 Jun; 43(2):194-201. PubMed ID: 15729700
[TBL] [Abstract][Full Text] [Related]
72. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
73. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy.
Ramburan A; Oladiran F; Smith C; Hadley GP; Govender D
J Clin Pathol; 2005 Jan; 58(1):44-50. PubMed ID: 15623481
[TBL] [Abstract][Full Text] [Related]
74. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
75. APC mutations and other genetic and epigenetic changes in colon cancer.
Samowitz WS; Slattery ML; Sweeney C; Herrick J; Wolff RK; Albertsen H
Mol Cancer Res; 2007 Feb; 5(2):165-70. PubMed ID: 17293392
[TBL] [Abstract][Full Text] [Related]
76. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.
Li JN; Zhao L; Wu J; Wu B; Yang H; Zhang HH; Qian JM
J Dig Dis; 2012 Jan; 13(1):24-32. PubMed ID: 22188913
[TBL] [Abstract][Full Text] [Related]
77. Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence.
Sedivy R; Wolf B; Kalipciyan M; Steger GG; Karner-Hanusch J; Mader RM
Br J Cancer; 2000 Apr; 82(7):1276-82. PubMed ID: 10755401
[TBL] [Abstract][Full Text] [Related]
78. [Activation of K-ras and c-erbB-2 protooncogenes in human colonic adenocarcinomas].
Golijow C; Güerci A; Mourón S; Abba M; Dulout FN; Ottino A; Pianzola H
Acta Gastroenterol Latinoam; 2001 May; 31(2):71-6. PubMed ID: 11471321
[TBL] [Abstract][Full Text] [Related]
79. APC mutations in synovial sarcoma.
Saito T; Oda Y; Sakamoto A; Kawaguchi K; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2002 Apr; 196(4):445-9. PubMed ID: 11920741
[TBL] [Abstract][Full Text] [Related]
80. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
